Deregulation of both EZH2 and DNMTs has been reported in AML, resulting in histone and DNA hypermethylation and consequently aberrant silencing of tumor suppressor genes such as BIM and CDKN2B (p15) [32, 33]. This evidence concerns the gene CDKN2B and acute myeloid leukemia.